NSAIDs may reduce risk of prostate cancer, study suggests
Patients who have or are at risk for prostate cancer may save a significant amount of money on the medications they need by purchasing from a Canadian internet pharmacy.
Patients who have or are at risk for prostate cancer may save a significant amount of money on the medications they need by purchasing from a Canadian internet pharmacy. The disease affects millions of men all over the world each year. Recently, a study published in the journal Cancer Epidemiology, Biomarkers and Prevention revealed that taking 30 tablets of acetaminophen every month for five years could reduce the risk of prostate cancer by as much as 38 percent.
The use of nonsteroidal anti-inflammatory drugs (NSAIDs) such as aspirin has been associated with modest reductions in the risk of this disease in some studies. Although acetaminophen is not considered a NSAID, researchers say that it does have anti-inflammatory properties.
Lead investigator Eric Jacobs and his team evaluated data from 78,485 men who had taken part in the Cancer Prevention Study II Nutrition Cohort. The researchers found that those who regularly used acetominophen had a lower risk of prostate cancer, compared to those who did not.
"While the results of this observational study suggest that long-term regular acetaminophen use may be associated with lower prostate cancer risk, our findings require replication by other studies and do not justify the use of acetaminophen to prevent prostate cancer," Jacobs concluded.
|
